Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Frequently Asked Questions About the 4-Drug Fixed-dose Combination Tablet Recommended by the World Health Organization for Treating Tuberculosis

This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB.

Author:

Stop TB Partnership

Audiences:

International Agencies

Topic:

TB Treatment, Treatment- Medication Information

Language:

English

Related Materials

Frequently Asked Questions About TB

This fact sheet provides basic information about TB.

Fact Sheet

Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed-Dose Combination Drugs

This guide assists in making TB control policy decisions and plans for successfully introducing fixed-dose combination drugs (FDCs). This guide is intended for national TB program managers, DOTS strategy implementers, drug procurement officers/personnel, DOT providers, and drug regulatory authorities.

Guideline

Frequently Asked Questions about XDR-TB

This fact sheet covers frequently asked questions regarding extensively drug-resistant tuberculosis (XDR-TB). Information on the medical definition, transmission, symptoms, diagnosis, treatment, and prevention are included. The fact sheet also addresses travel safety, the link to HIV/AIDS, and WHO's actions to combat XDR-TB.

Fact Sheet

Global resources for the prevention,
management, and elimination of TB.